Valuation: Ipca Laboratories Limited

Market Cap 418B 4.42B 3.87B 3.57B 3.34B 6.28B 6.42B 43B 16.6B 206B 16.6B 16.24B 716B P/E 2026
35.6x
P/E 2027 * 29.9x
Enterprise Value 413B 4.37B 3.82B 3.53B 3.3B 6.21B 6.35B 42.48B 16.4B 204B 16.4B 16.04B 707B EV / Sales 2026
4.24x
EV / Sales 2027 * 3.75x
Free-Float
54.92%
Yield 2026
0.37%
Yield 2027 * 0.35%
1 day+1.79%
1 week+3.87%
Current month+8.06%
1 month+4.76%
3 months+3.86%
6 months+14.40%
Current year+16.09%
1 week 1,599.9
Extreme 1599.9
1,664.9
1 month 1,470
Extreme 1470
1,670
Current year 1,391.8
Extreme 1391.8
1,678.3
1 year 1,251.6
Extreme 1251.6
1,678.3
3 years 737.5
Extreme 737.5
1,755.9
5 years 669.8
Extreme 669.8
1,755.9
10 years 200
Extreme 200
1,755.9
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Date Insider Type Main position Quantity % Market Cap.
19/12/24Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
+1.79%+3.87%+23.69%+120.80% 4.35B
+1.69%+11.26%+57.29%+163.97% 1,077B
+1.15%+11.27%+68.49%+56.83% 613B
+0.75%+10.75%+37.24%+91.20% 448B
+1.86%+4.85%+28.17%+22.04% 332B
-0.14%+7.58%+41.28%+27.25% 293B
-0.06%+4.92%+31.23%+41.59% 286B
-0.96%+4.98%-28.37%-40.96% 215B
+0.34%+4.44%+28.95%+62.80% 193B
-1.60%+0.79%+13.52%+65.58% 159B
Average +0.50%+8.11%+30.15%+61.11% 362.04B
Weighted average by Cap. +0.85%+9.65%+42.13%+81.15%

Financials

2026 2027 *
Net sales 96.62B 1.02B 895M 826M 771M 1.45B 1.49B 9.94B 3.84B 47.66B 3.84B 3.75B 165B 108B 1.14B 998M 921M 860M 1.62B 1.66B 11.08B 4.28B 53.14B 4.28B 4.18B 184B
Net income 11.21B 119M 104M 95.82M 89.48M 168M 172M 1.15B 445M 5.53B 445M 435M 19.2B 14.04B 148M 130M 120M 112M 211M 216M 1.44B 558M 6.92B 558M 545M 24.04B
Net Debt -5.02B -53.07M -46.46M -42.89M -40.06M -75.4M -77.12M -516M -199M -2.48B -199M -195M -8.59B -14.5B -153M -134M -124M -116M -218M -223M -1.49B -576M -7.15B -576M -563M -24.83B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
16,778
Date Price Change Volume
29/06/26 INR 1,647.20 +1.79% 333,883
25/06/26 INR 1,618.30 -0.18% 167,145
24/06/26 INR 1,621.20 -0.23% 116,670
23/06/26 INR 1,625.00 +1.73% 179,904
22/06/26 INR 1,597.30 +0.73% 86,624
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,647.20INR
Average target price
1,719.61INR
Spread / Average Target
+4.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IPCALAB Stock